These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 24804687)
61. Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age (Review). De-Regil LM; Suchdev PS; Vist GE; Walleser S; Peña-Rosas JP Evid Based Child Health; 2013 Jan; 8(1):112-201. PubMed ID: 23878126 [TBL] [Abstract][Full Text] [Related]
62. Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design. Brams M; Weisler R; Findling RL; Gasior M; Hamdani M; Ferreira-Cornwell MC; Squires L J Clin Psychiatry; 2012 Jul; 73(7):977-83. PubMed ID: 22780921 [TBL] [Abstract][Full Text] [Related]
63. Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioning. Wietecha L; Young J; Ruff D; Dunn D; Findling RL; Saylor K Clin Neuropharmacol; 2012; 35(3):125-33. PubMed ID: 22561876 [TBL] [Abstract][Full Text] [Related]
64. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. Rösler M; Retz W; Fischer R; Ose C; Alm B; Deckert J; Philipsen A; Herpertz S; Ammer R World J Biol Psychiatry; 2010 Aug; 11(5):709-18. PubMed ID: 20353312 [TBL] [Abstract][Full Text] [Related]
65. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study. Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533 [TBL] [Abstract][Full Text] [Related]
66. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Handen BL; Aman MG; Arnold LE; Hyman SL; Tumuluru RV; Lecavalier L; Corbett-Dick P; Pan X; Hollway JA; Buchan-Page KA; Silverman LB; Brown NV; Rice RR; Hellings J; Mruzek DW; McAuliffe-Bellin S; Hurt EA; Ryan MM; Levato L; Smith T J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):905-15. PubMed ID: 26506581 [TBL] [Abstract][Full Text] [Related]
68. Impact of Micronutrients on Hypertension: Evidence from Clinical Trials with a Special Focus on Meta-Analysis. Chiu HF; Venkatakrishnan K; Golovinskaia O; Wang CK Nutrients; 2021 Feb; 13(2):. PubMed ID: 33578935 [TBL] [Abstract][Full Text] [Related]
69. Nutrition in the Management of ADHD: A Review of Recent Research. Lange KW; Lange KM; Nakamura Y; Reissmann A Curr Nutr Rep; 2023 Sep; 12(3):383-394. PubMed ID: 37505402 [TBL] [Abstract][Full Text] [Related]
70. Efficacy and cost of micronutrient treatment of childhood psychosis. Rodway M; Vance A; Watters A; Lee H; Bos E; Kaplan BJ BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23144350 [TBL] [Abstract][Full Text] [Related]
71. Human gut microbiome changes during a 10 week Randomised Control Trial for micronutrient supplementation in children with attention deficit hyperactivity disorder. Stevens AJ; Purcell RV; Darling KA; Eggleston MJF; Kennedy MA; Rucklidge JJ Sci Rep; 2019 Jul; 9(1):10128. PubMed ID: 31300667 [TBL] [Abstract][Full Text] [Related]
72. [Subclinical micronutrients deficiencies related to metabolic syndrome]. Jiménez Ortega AI; Martínez García RM; Velasco Rodríguez-Belvis M; Ruiz Herrero J; Salas González MªD; Ortega RM Nutr Hosp; 2018 Sep; 35(Spec No6):60-63. PubMed ID: 30351164 [TBL] [Abstract][Full Text] [Related]
73. Broad-spectrum micronutrient treatment for attention-deficit/hyperactivity disorder: rationale and evidence to date. Rucklidge JJ; Kaplan BJ CNS Drugs; 2014 Sep; 28(9):775-85. PubMed ID: 25056569 [TBL] [Abstract][Full Text] [Related]
75. Effect of micronutrient malnutrition on periodontal disease and periodontal therapy. Dommisch H; Kuzmanova D; Jönsson D; Grant M; Chapple I Periodontol 2000; 2018 Oct; 78(1):129-153. PubMed ID: 30198127 [TBL] [Abstract][Full Text] [Related]
76. Blinding of Participants to Treatment and Implications for Assessments of Efficacy in Attention-Deficit/Hyperactivity Disorder Micronutrient Study. Hamilton J J Am Acad Child Adolesc Psychiatry; 2023 Nov; 62(11):1167-1168. PubMed ID: 37543078 [No Abstract] [Full Text] [Related]
77. Protocol for a randomised placebo-controlled trial investigating the efficacy and safety of a vitamin-mineral formula targeting dysregulated emotions in teenagers: The balancing emotions of adolescents with micronutrients (BEAM) study. Rucklidge JJ; Blampied FM; Manna L; Sherwin A; Bagshaw S; Mulder RT; Boden J Contemp Clin Trials Commun; 2022 Dec; 30():101027. PubMed ID: 36340698 [TBL] [Abstract][Full Text] [Related]
78. Dr. Johnstone et al. Reply to Dr. Elmrayed. Johnstone JM; Arnold LE; Villagomez A; Robinette LM; Gracious BL; Ast HK; Bruton AM; Hatsu IE J Am Acad Child Adolesc Psychiatry; 2023 Nov; 62(11):1171-1175. PubMed ID: 37543077 [TBL] [Abstract][Full Text] [Related]
79. Broad spectrum micronutrient formulas for the treatment of symptoms of depression, stress, and/or anxiety: a systematic review. Blampied M; Bell C; Gilbert C; Rucklidge JJ Expert Rev Neurother; 2020 Apr; 20(4):351-371. PubMed ID: 32178540 [No Abstract] [Full Text] [Related]